Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.41 USD | +1.18% | -11.91% | +24.73% |
May. 09 | Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | HC Wainwright Starts Adverum Biotechnologies With Buy Rating, $30 Price Target | MT |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.